Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine

Molecules and Cells

Volumn 26, Issue 1, 2008, Pages 18-25

  Han, Yong Hwan ^a   Kim, Sung Zoo ^a   Kim, Suhn Hee ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Arsenic trioxide; GSH; HeLa; ROS; ROS scavenger

Indexed keywords

ACETYLCYSTEINE; ARSENIC TRIOXIDE; CATALASE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; TEMPOL; TIRON; TRIMETAZIDINE; ANTINEOPLASTIC AGENT; GROWTH INHIBITOR; ORGANOARSENIC DERIVATIVE; OXIDE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; OXYGEN CONCENTRATION; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN FUNCTION; UPREGULATION; DRUG EFFECT; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CATALASE; CELL CYCLE; FREE RADICAL SCAVENGERS; GLUTATHIONE; GROWTH INHIBITORS; HELA CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 53449092255     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Baj, G., Arnulfo, A., Deaglio, S., Mallone, R., Vigone, A., De Cesaris, M.G., Surico, N., Malavasi, F., and Ferrero, E. (2002). Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res. Treat. 73, 61-73.
2. Baran, C.P., Zeigler, M.M., Tridandapani, S., and Marsh, C.B. (2004). The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des. 10, 855-866.
3. Bubici, C., Papa, S., Pham, C.G., Zazzeroni, F., and Franzoso, G. (2006). The NF-kappaB-mediated control of ROS and JNK signaling. Histol. Histopathol. 21, 69-80.
4. Chen, T.J., Jeng, J.Y., Lin, C.W., Wu, C.Y., and Chen, Y.C. (2006). Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223, 113-126.
5. Cuzzocrea, S., McDonald, M.C., Mazzon, E., Siriwardena, D., Costantino, G., Fulia, F., Cucinotta, G., Gitto, E., Cordaro, S., Barberi, I., et al. (2000). Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res. 875, 96-106.
6. Dai, J., Weinberg, R.S., Waxman, S., and Jing, Y. (1999). Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277.
7. Dasmahapatra, G., Rahmani, M., Dent, P., and Grant, S. (2006). The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107, 232-240.
8. Gonzalez, C., Sanz-Alfayate, G., Agapito, M.T., Gomez-Nino, A., Rocher, A., and Obeso, A. (2002). Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir. Physiol. Neurobiol. 132, 17-41.
9. Greenstock, C.L., and Miller, R.W. (1975). The oxidation of tiron by superoxide anion. Kinetics of the reaction in aqueous solution in chloroplasts. Biochim. Biophys. Acta. 396, 11-16.
10. Haga, N., Fujita, N., and Tsuruo, T. (2005). Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells. Cancer science 96, 825-833.
11. Han, S.S., Kim, K., Hahm, E.R., Park, C.H., Kimler, B.F., Lee, S.J., Lee, S.H., Kim, W.S., Jung, C.W., Park, K., et al. (2005). Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J. Cell. Biochem. 94, 695-707.
12. Han, Y.H., Kim, S.Z., Kim, S.H., and Park, W.H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. Renal. Physiol. 293, F511-520.
13. Han, Y.H., Kim, S.H., Kim, S.Z., and Park, W.H. (2008a). Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels. J. Cell. Biochem. 104, 862-878.
14. Han, Y.H., Kim, S.Z., Kim, S.H., and Park, W.H. (2008b). Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide. J. Cell. Biochem. 104, 995-1009.
15. Hedley, D.W., and Chow, S. (1994). Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15, 349-358.
16. Hyun Park, W., Hee Cho, Y., Won Jung, C., Oh Park, J., Kim, K., Hyuck Im, Y., Lee, M.H., Ki Kang, W., and Park, K. (2003). Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun. 300, 230-235.
17. Jing, Y., Dai, J., Chalmers-Redman, R.M., Tatton, W.G., and Waxman, S. (1999). Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94, 2102-2111.
18. Kang, Y.H., Yi, M.J., Kim, M.J., Park, M.T., Bae, S., Kang, C.M., Cho, C.K., Park, I.C., Park, M.J., Rhee, C.H. et al. (2004). Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64, 8960-8967.
19. Khan, N.S., Ahmad, A., and Hadi, S.M. (2000). Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chem. Biol. Interact. 125, 177-189.
20. Kim, H.R., Kim, E.J., Yang, S.H., Jeong, E.T., Park, C., Kim, S.J., Youn, M.J., So, H.S., and Park, R. (2006). Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. Int. J. Oncol. 28, 1401-1408.
21. Kitamura, K., Minami, Y., Yamamoto, K., Akao, Y., Kiyoi, H., Saito, H., and Naoe, T. (2000). Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14, 1743-1750.
22. Kito, M., Akao, Y., Ohishi, N., Yagi, K., and Nozawa, Y. (2002). Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 291, 861-867.
23. Lauterburg, B.H. (2002). Analgesics and glutathione. Am. J. Ther. 9, 225-233.
24. Li, J.J., Tang, Q., Li, Y., Hu, B.R., Ming, Z.Y., Fu, Q., Qian, J.Q., and Xiang, J.Z. (2006). Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta. Pharmacol. Sin. 27, 1078-1084.
25. Li, M., Cai, J.F., and Chiu, J.F. (2002). Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J. Cell. Biochem. 87, 29-38.
26. Macho, A., Hirsch, T., Marzo, I., Marchetti, P., Dallaporta, B., Susin, S.A., Zamzami, N., and Kroemer, G. (1997). Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J. Immunol. 158, 4612-4619.
27. Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., and Kakizuka, A. (2004). Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ. 11, 737-746.
28. Miller, W.H., Jr., Schipper, H.M., Lee, J.S., Singer, J., and Waxman, S. (2002). Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903.
29. Nakagawa, Y., Akao, Y., Morikawa, H., Hirata, I., Katsu, K., Naoe, T., Ohishi, N., and Yagi, K. (2002). Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci. 70, 2253-2269.
30. Oketani, M., Kohara, K., Tuvdendorj, D., Ishitsuka, K., Komorizono, Y., Ishibashi, K., and Arima, T. (2002). Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett. 183, 147-153.
31. Park, W.H., Seol, J.G., Kim, E.S., Hyun, J.M., Jung, C.W., Lee, C.C., Kim, B.K., and Lee, Y.Y. (2000). Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 60, 3065-3071.
32. Park, W.H., Jung, C.W., Park, J.O., Kim, K., Kim, W.S., Im, Y.H., Lee, M.H., Kang, W.K., and Park, K. (2003). Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int. J. Oncol. 22, 1129-1134.
33. Poot, M., Teubert, H., Rabinovitch, P.S., and Kavanagh, T.J. (1995). De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 163, 555-560.
34. Pu, Y.S., Hour, T.C., Chen, J., Huang, C.Y., Guan, J.Y., and Lu, S.H. (2002). Cytotoxicity of arsenic trioxide to transitional carcinoma cells. Urology 60, 346-350.
35. Schnelldorfer, T., Gansauge, S., Gansauge, F., Schlosser, S., Beger, H.G., and Nussler, A.K. (2000). Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89, 1440-1447.
36. Scott, N., Hatlelid, K.M., MacKenzie, N.E., and Carter, D.E. (1993). Reactions of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6, 102-106.
37. Seol, J.G., Park, W.H., Kim, E.S., Jung, C.W., Hyun, J.M., Kim, B.K., and Lee, Y.Y. (1999). Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem. Biophys. Res. Commun. 265, 400-404.
38. Shen, Z.Y., Shen, W.Y., Chen, M.H., Shen, J., and Zeng, Y. (2003). Reactive oxygen species and antioxidants in apoptosis of esophageal cancer cells induced by As2O3. Int. J. Mol. Med. 11, 479-484.
39. Shim, H.Y., Park, J.H., Paik, H.D., Nah, S.Y., Kim, D.S., and Han, Y.S. (2007). Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/ JNK1/2-c-Jun activation. Mol. Cells 24, 95-104.
40. Simon, H.U., Haj-Yehia, A., and Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418.
41. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., et al. (1998). Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339, 1341-1348.
42. Stanley, W.C., and Marzilli, M. (2003). Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Fundam. Clin. Pharmacol. 17, 133-145.
43. Tikhaze, A.K., Lankin, V.Z., Zharova, E.A., and Kolycheva, S.V. (2000). Trimetazidine as indirect antioxidant. Bull. Exp. Biol. Med. 130, 951-953.
44. Uslu, R., Sanli, U.A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S.B., and Goker, E. (2000). Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res. 6, 4957-4964.
45. Wallach-Dayan, S.B., Izbicki, G., Cohen, P.Y., Gerstl-Golan, R., Fine, A., and Breuer, R. (2006). Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L790-L796.
46. Wang, Z.G., Rivi, R., Delva, L., Konig, A., Scheinberg, D.A., Gambacorti-Passerini, C., Gabrilove, J.L., Warrell, R.P., Jr., and Pandolfi, P.P. (1998). Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 92, 1497-1504.
47. Wilcox, C.S. (2002). Reactive oxygen species: roles in blood pressure and kidney function. Curr. Hypertens Rep. 4, 160-166.
48. Woo, S.H., Park, I.C., Park, M.J., Lee, H.C., Lee, S.J., Chun, Y.J., Lee, S.H., Hong, S.I., and Rhee, C.H. (2002). Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int. J. Oncol. 21, 57-63.
49. Wu, X.X., Ogawa, O., and Kakehi, Y. (2004). Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Int. J. Oncol. 24, 1489-1497.
50. Yamada, J., Yoshimura, S., Yamakawa, H., Sawada, M., Nakagawa, M., Hara, S., Kaku, Y., Iwama, T., Naganawa, T., Banno, Y., et al. (2003). Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci. Res. 45, 1-8.
51. Zhang, T.C., Cao, E.H., Li, J.F., Ma, W., and Qin, J.F. (1999). Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35, 1258-1263.
52. Zhang, W., Ohnishi, K., Shigeno, K., Fujisawa, S., Naito, K., Nakamura, S., Takeshita, K., Takeshita, A., and Ohno, R. (1998). The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12, 1383-1391.
53. Zorov, D.B., Juhaszova, M., and Sollott, S.J. (2006). Mitochondrial ROS-induced ROS release: An update and review. Biochem. Biophys. Acta. 1757, 509-517.